These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23101455)

  • 21. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.
    Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications.
    Kumar J; Ward AC
    Biochim Biophys Acta; 2014 Apr; 1845(2):117-25. PubMed ID: 24388871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
    Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
    Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma.
    Ritprajak P; Azuma M
    Oral Oncol; 2015 Mar; 51(3):221-8. PubMed ID: 25500094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmin triggers cytokine induction in human monocyte-derived macrophages.
    Li Q; Laumonnier Y; Syrovets T; Simmet T
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1383-9. PubMed ID: 17413040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics and non-canonical aspects of JAK/STAT signalling.
    Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
    Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.
    Tao W; Wen F; Zhang H; Liu G
    Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma.
    Wang YF; Chang SY; Tai SK; Li WY; Wang LS
    Head Neck; 2002 Sep; 24(9):850-8. PubMed ID: 12211049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutics targeting innate immune/inflammatory responses through the interleukin-6/JAK/STAT signal transduction pathway in patients with cancer.
    Roxburgh CS; McMillan DC
    Transl Res; 2016 Jan; 167(1):61-6. PubMed ID: 26432924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Godoy-Tundidor S; Cavarretta IT; Fuchs D; Fiechtl M; Steiner H; Friedbichler K; Bartsch G; Hobisch A; Culig Z
    Prostate; 2005 Jul; 64(2):209-16. PubMed ID: 15712220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 signaling pathway in targeted therapy for cancer.
    Guo Y; Xu F; Lu T; Duan Z; Zhang Z
    Cancer Treat Rev; 2012 Nov; 38(7):904-10. PubMed ID: 22651903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway.
    Wei LH; Kuo ML; Chen CA; Chou CH; Cheng WF; Chang MC; Su JL; Hsieh CY
    Oncogene; 2001 Sep; 20(41):5799-809. PubMed ID: 11593385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Squarize CH; Castilho RM; Sriuranpong V; Pinto DS; Gutkind JS
    Neoplasia; 2006 Sep; 8(9):733-46. PubMed ID: 16984731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
    Galdiero M; Vitiello M; D'Isanto M; Raieta K; Galdiero E
    Cytokine; 2006 Dec; 36(5-6):218-28. PubMed ID: 17258468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis.
    Fontaine RH; Cases O; Lelièvre V; Mesplès B; Renauld JC; Loron G; Degos V; Dournaud P; Baud O; Gressens P
    Cell Death Differ; 2008 Oct; 15(10):1542-52. PubMed ID: 18551134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 and interleukin-11: same same but different.
    Garbers C; Scheller J
    Biol Chem; 2013 Sep; 394(9):1145-61. PubMed ID: 23740659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer.
    Haura EB; Livingston S; Coppola D
    Clin Lung Cancer; 2006 Jan; 7(4):273-5. PubMed ID: 16512982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.
    Matsuoka Y; Nakayama H; Yoshida R; Hirosue A; Nagata M; Tanaka T; Kawahara K; Sakata J; Arita H; Nakashima H; Shinriki S; Fukuma D; Ogi H; Hiraki A; Shinohara M; Toya R; Murakami R
    Br J Cancer; 2016 Nov; 115(10):1234-1244. PubMed ID: 27736845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 and prostate cancer: Current developments and unsolved questions.
    Culig Z; Puhr M
    Mol Cell Endocrinol; 2018 Feb; 462(Pt A):25-30. PubMed ID: 28315704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach.
    Aliyu M; Zohora FT; Anka AU; Ali K; Maleknia S; Saffarioun M; Azizi G
    Int Immunopharmacol; 2022 Oct; 111():109130. PubMed ID: 35969896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.